Log in | Register

Bag Ports that Meet Biopharm Requirements

For the latest pharmaceutical news and updates - Sign up now!
Loading...
Bag Ports that Meet Biopharm Requirements

The company has introduced a technologically advanced series of ports for the single-use bags used to transfer media and drug compounds in the biopharmaceutical industry. They offer a variety of new benefits to biomanufacturers, including the specific benefits of the Value Pharma™ material, such as: animal derivative-free qualification, USP Class VI certification, guaranteed heat sealing and conformance with polyethylene bags, and 24-hour resistance to alcohol stress cracking — a critical feature when processing materials that can cost thousands of dollars per liter. The new bag ports also incorporate two unique features that reduce process time and potential damage to expensive media. Parabolic lead-ins on the ports save time by shortening the time required to drain a bag by up to 24 percent, while  alignment ribs improve fluid flow dynamics by reducing shear impact as material exits the bag. For widespread industry compatibility, the new ports are designed to work with common tubing sizes, as well as industry-standard fittings, filters and other devices.

Value Plastics, Fort Collins, CO 80525.  www.valueplastics.com or call 888-404-5837

INTERPHEX 2012 Booth No. 2722

 

Register or log in to send e-mail for more info

E-mail to a colleague

See company's other products

Join the Discussion
Rate Article:  Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Blogs

The Tale of Two Deviations

The Tale of Two Deviations

Apr 23 | The QA Pharm

It stands to reason that pharmaceutical companies in compliance trouble also have problems with their Deviation Management and Corrective and Preventive Action (CAPA) System(s).

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Apr 16 | Girish Malhotra, PE, President, EPCOT International

The answer is an unequivocal yes but we need some outsiders who can conspire with the insiders who will be the flag bearers within the companies. Outsiders can be the counsels/co-conspirators to the insiders for the coup d'etat.

Multimedia

Lung Cancer Drug Treats Rare Lymphoma Tumors

Lung Cancer Drug Treats Rare Lymphoma Tumors

May 17 | Video

A new study found Xalkori effective in treating anaplastic lymphoma among children, an encouraging development for gene-targeted therapy.

Merck - 2012 Facility of the Year Award - Facility Integration

Merck - 2012 Facility of the Year Award - Facility Integration

May 14 | Video

Brian Morrissey, Senior Project Engineer, Merck Manufacturing Division, talks to Pharmaceutical Processing's Editor In Chief Mike Auerbach during INTERPHEX 2012 about the company's Vaccine Bulk Manufacturing Facility Program of Projects. The facility has won the Facility Integration award in the 2012 Facility of the Year Award competition sponsored by ISPE, INTERPHEX and Pharmaceutical Processing magazine.

Medicine from a Vending Machine?

Medicine from a Vending Machine?

May 3 | Video

A Chinese company is pushing for acceptance of traditional Chinese medicine with a machine that can dispense herbs.

Taking Precautions to Prevent Contagion

Taking Precautions to Prevent Contagion

Apr 29 | Video

With the recent outbreak of viruses such as SARS, bird flu and swine flu, officials and travelers are being extra careful about preventing the illnesses from being transmitted.

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter